Contract orientation & kickoff meeting for r & d services under "preclinical toxicology of small molecule drugs developed for cancer and other indications"
Ended Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,708
Award facts
- Contract value 100% obligated
- $2,708.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Close Out | -$292 | |
| Other Administrative Action | $0 | |
| Original award | $3,000 |
About this award
This contract award represents a delivery order for a contract orientation and kickoff meeting related to preclinical toxicology research services for small molecule drugs developed for cancer and other indications. The National Cancer Institute (NCI) awarded this delivery order to IIT Research Institute (IITRI), a nonprofit contract research organization and subsidiary of the Illinois Institute of Technology located in Chicago, Illinois. The contract carries a ceiling value of $2,708.00 and operates under a cost-plus-fixed-fee pricing structure with no set-aside designation, indicating it was awarded through full and open competition. The ultimate completion date is April 25, 2025, with the award date of September 26, 2022. This delivery order is issued under a larger $9.8 million single-award IDIQ vehicle with the National Cancer Institute that covers preclinical toxicology of small molecule drugs for cancer and other indications, running through September 2029.
IITRI specializes in providing comprehensive preclinical drug development services to federal agencies within the National Institutes of Health ecosystem, with particular expertise in toxicology studies, safety evaluations, and pharmacokinetic analyses supporting investigational new drug applications. The organization conducts both GLP and non-GLP toxicology studies using rodent and canine models, as well as dose range finding and efficacy assessments across various therapeutic areas. The kickoff meeting and contract orientation documented in this award facilitate coordination and communication necessary to execute the preclinical toxicology services under the larger NCI vehicle, establishing the framework for research activities that support the agency's cancer prevention and treatment initiatives.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 26, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $2,708 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a delivery order under 75N91022D00016, an indefinite delivery contract.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award